| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18782113 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 102 journal articles in the PubMed database | Email to a friend | | |
| Rolinck-Werninghaus C, Keil T, Kopp M, et al.
Specific IgE serum concentration is associated with symptom severity in children with seasonal allergic rhinitis. [JOURNAL ARTICLE]
Allergy 2008 Oct; 63(10):1339-1344.
Abstract | Full Citation | Find Related Articles | | Kopp MV, Brauburger J, Riedinger F, et al.
The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Allergy Clin Immunol 2002 Nov; 110(5):728-35.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kuehr J, Brauburger J, Zielen S, et al.
Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. [Clinical Trial, Journal Article, Randomized Controlled Trial]
J Allergy Clin Immunol 2002 Feb; 109(2):274-80.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Casale TB, Condemi J, LaForce C, et al.
Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
JAMA 2001 Dec 19; 286(23):2956-67.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Rolinck-Werninghaus C, Hamelmann E, Keil T, et al.
The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Allergy 2004 Sep; 59(9):973-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Winther L, Moseholm L, Reimert CM, et al.
Basophil histamine release, IgE, eosinophil counts, ECP, and EPX are related to the severity of symptoms in seasonal allergic rhinitis. [Journal Article]
Allergy 1999 May; 54(5):436-45.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Beeh KM, Beier J, Buhl R
[Seasonal variations of serum-IgE and potential impact on dose-calculation of omalizumab (rhuMab-E25, anti-IgE)] [Journal Article]
Pneumologie 2004 Aug; 58(8):546-51.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Adelroth E, Rak S, Haahtela T, et al.
Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Allergy Clin Immunol 2000 Aug; 106(2):253-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Okubo K, Ogino S, Nagakura T, et al.
Omalizumab is Effective and Safe in the Treatment of Japanese Cedar Pollen-induced Seasonal Allergic Rhinitis. [Journal Article]
Allergol Int 2006 Dec; 55(4):379-86.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
